Effect of Insulin-Regulated FOXC2 Expression in Adipocyte Differentiation and Insulin Resistance

References

• Rutscher K, Wilting J. Transcription factor FOXC2 demarcates the jugular lymphangiogenic region in avian embryos. Lymphology. 2008;41(1):11–17.
   PubMedGoogle Scholar
• Jag UR, Zavadil J, Stanley FM. Insulin acts through FOXO3a to activate transcription of plasminogen activator inhibitor type 1. Mol Endocrinol. 2009;23(10):1587–1602. doi:10.1210/me.2008-0421
   PubMedGoogle Scholar
• Datta N, Lindfors S, Miura N, et al. Overexpression of transcription factor FOXC2 in cultured human podocytes upregulates injury markers and increases motility. Exp Cell Res. 2016;340:32–42. doi:10.1016/j.yexcr.2015.10.035
   PubMed Web of Science ®Google Scholar
• Yang X, Enerback S, Smith U. Reduced expression of FOXC2 and brown adipogenic genes in human subjects with insulin resistance. Obes Res. 2003;11:1182–1191. doi:10.1038/oby.2003.163
   PubMedGoogle Scholar
• Kim JK, Kim HJ, Park SY, et al. Transgenic mice overexpressing FOXC2 are z from high diet-induced insulin resistance in skeletal muscle and liver. Diabetes. 2003;52(Suppl 1):A314.
   Google Scholar
• Cederberg A, Gronning LM, Ahren B, Tasken K, Carlsson P, Enerback S. FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced insulin resistance. Cell. 2001;106:563–573. doi:10.1016/S0092-8674(01)00474-3
   PubMed Web of Science ®Google Scholar
• Gjedde S, Gormsen LC, Riis AL, et al. Reduced expression of uncoupling protein 2 in adipose tissue in patients with hypothyroidism. J Clin Endocrinol Metab. 2010;95(7):3537–3541. doi:10.1210/jc.2009-0907
   PubMedGoogle Scholar
• Dahle MK, Gronning LM, Cederberg A, et al. Mechanisms of FOXC2- and FOXD1-mediated regulation of the RI alpha subunit of cAMP-dependent protein kinase include release of transcriptional repression and activation by protein kinase B alpha and cAMP. J Biol Chem. 2002;277(25):22902–22908. doi:10.1074/jbc.M200131200
   PubMed Web of Science ®Google Scholar
• Kim JK, Kim HJ, Park SY, et al. Adipocyte-specific over expression of FOXC2 prevents diet-induced increases in intramuscular fatty acyl CoA and insulin resistance. Diabetes. 2005;54(6):1657–1673. doi:10.2337/diabetes.54.6.1657
   PubMedGoogle Scholar
• Ferrell RE, Kimmak MA, Lawrence EC, et al. Candidate gene analysis in primary lymphedema. Lymphat Res Biol. 2008;6(2):69–76. doi:10.1089/lrb.2007.1022
   PubMedGoogle Scholar
• Ridderstråle M, Carlsson E, Klannemark M, et al. FOXC2 mRNA expression and a 5ʹuntranslated region polymorphism of the gene are associated with insulin resistance. Diabetes. 2002;51(12):3554–3560. doi:10.2337/diabetes.51.12.3554
   PubMedGoogle Scholar
• Yildirim-Toruner C, Subramanian K, El Manjra L, Chen E, Goldstein S, Vitale E. A novel frameshift mutation of FOXC2 gene in a family with hereditary lymphedema-distichiasis syndrome associated with renal disease and diabetes mellitus. Am J Med Genet A. 2004;131(3):281–286. doi:10.1002/ajmg.a.30390
   PubMedGoogle Scholar
• Carlsson E, Groop L, Ridderstråle M. Role of the FOXC2-512C>T polymorphism in Type 2 diabetes: possible association with the dysmetabolic syndrome. Int J Obes (Lond). 2005;29(3):268–274. doi:10.1038/sj.ijo.0802876
   PubMedGoogle Scholar
• Carlsson E, Almgren P, Hoffstedt J, Groop L, Martin R. The FOXC2 C-512T polymorphism is associated with obesity and dyslipidemia. Obes Res. 2004;12(11):1738–1743. doi:10.1038/oby.2004.215
   PubMedGoogle Scholar
• Kovacs P, Lehn-Stefan A, Stumvoll M, et al. Genetic variation in the human winged helix/forkhead transcription factor gene FOXC2 in Pima Indians. Diabetes. 2003;52(5):1292–1295. doi:10.2337/diabetes.52.5.1292
   PubMedGoogle Scholar
• Davis KE, Moldes M, Farmer SR. The forkhead transcription factor FoxC2 inhibits white adipocyte differentiation. J Biol Chem. 2004;279(41):42453–42461. doi:10.1074/jbc.M402197200
   PubMedGoogle Scholar
• Gaster M, Staehr P, Beck Nielsen H, Schroder HD, Handberg A. GLUT4 is reduced in slow muscle fibers of type 2 diabetic patients: is insulin resistance in type 2 diabetes a slow, type 1 fiber disease. Diabetes. 2001;50(6):1324–1329. doi:10.2337/diabetes.50.6.1324
   PubMed Web of Science ®Google Scholar
• Abel ED, Peron IO, Kimi JK, et al. Adipose selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature. 2001;409(6821):729–733. doi:10.1038/35055575
   PubMed Web of Science ®Google Scholar
• Delporte ML, Funahashi T. Pre and post translational negative effect of adrenoceptor agonists on adiponectin secretion: in vitro and in vivo. Biochem J. 2002;367:677. doi:10.1042/bj20020610
   PubMedGoogle Scholar
• Fujita H, Kang M, Eren M, Gleaves LA, Vaughan DE, Kume T. Foxc2 is a common mediator and insulin transforming growth factor beta signaling to regulate plasm inogen activator inhibitor type I gene expression. Circ Res. 2006;98(5):626–634. doi:10.1161/01.RES.0000207407.51752.3c
   PubMed Web of Science ®Google Scholar
• Katagiri S, Park K, Maeda Y. Overexpressing IRS1 in endothelial cells enhances angioblast differentiation and wound healing in diabetes and insulin resistance. Diabetes. 2016;65(9):2760–2771. doi:10.2337/db15-1721
   PubMedGoogle Scholar
• Yalverde AM, Benito M, Lorenzo M. The brown adipose cell: a model for understanding the molecular mechanisms of insulin resistance. Acta Physiol Scand. 2005;183:59–73. doi:10.1111/j.1365-201X.2004.01384.x
   PubMedGoogle Scholar
• Håkansson J, Eliasson B, Smith U, Enerbäck. S. Adipocyte mitochondrial genes and the forkhead factor FOXC2 are decreased in type 2 diabetes patients and normalized in response to rosiglitazone. Diabetol Metab Syndr. 2011;3:32–40. doi:10.1186/1758-5996-3-32
   PubMedGoogle Scholar